Pneumococcal Vaccines-Europe Market Status and Trend Report 2013-2023
Report Summary
Pneumococcal Vaccines-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pneumococcal Vaccines industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Pneumococcal Vaccines 2013-2017, and development forecast 2018-2023
Main market players of Pneumococcal Vaccines in Europe, with company and product introduction, position in the Pneumococcal Vaccines market
Market status and development trend of Pneumococcal Vaccines by types and applications
Cost and profit status of Pneumococcal Vaccines, and marketing status
Market growth drivers and challenges
The report segments the Europe Pneumococcal Vaccines market as:
Europe Pneumococcal Vaccines Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Pneumococcal Vaccines Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
PPSV 23
PCV 7/13
PCV 10
Europe Pneumococcal Vaccines Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
For Infants
For Children (2-10)
For Person (10-64)
For The Old (?65)
Europe Pneumococcal Vaccines Market: Players Segment Analysis (Company and Product introduction, Pneumococcal Vaccines Sales Volume, Revenue, Price and Gross Margin):
Pfizer
Sanofi
GSK
Merck
Eli Lilly
AstraZeneca
Abera
S K Chemicals
Beijing Minhai Biotechnology
Baxter
Biken
Celgene Corporation
Panacea Biotec
Serum Institute of India
Genentech
Genocea Biosciences
ImmunoBiology
Lupin
Nuron Biotech
Biogen
Valneva Austria
Sinovac
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Pneumococcal Vaccines-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pneumococcal Vaccines industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Pneumococcal Vaccines 2013-2017, and development forecast 2018-2023
Main market players of Pneumococcal Vaccines in Europe, with company and product introduction, position in the Pneumococcal Vaccines market
Market status and development trend of Pneumococcal Vaccines by types and applications
Cost and profit status of Pneumococcal Vaccines, and marketing status
Market growth drivers and challenges
The report segments the Europe Pneumococcal Vaccines market as:
Europe Pneumococcal Vaccines Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Pneumococcal Vaccines Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
PPSV 23
PCV 7/13
PCV 10
Europe Pneumococcal Vaccines Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
For Infants
For Children (2-10)
For Person (10-64)
For The Old (?65)
Europe Pneumococcal Vaccines Market: Players Segment Analysis (Company and Product introduction, Pneumococcal Vaccines Sales Volume, Revenue, Price and Gross Margin):
Pfizer
Sanofi
GSK
Merck
Eli Lilly
AstraZeneca
Abera
S K Chemicals
Beijing Minhai Biotechnology
Baxter
Biken
Celgene Corporation
Panacea Biotec
Serum Institute of India
Genentech
Genocea Biosciences
ImmunoBiology
Lupin
Nuron Biotech
Biogen
Valneva Austria
Sinovac
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF PNEUMOCOCCAL VACCINES
1.1 Definition of Pneumococcal Vaccines in This Report
1.2 Commercial Types of Pneumococcal Vaccines
1.2.1 PPSV
1.2.2 PCV 7/13
1.2.3 PCV
1.3 Downstream Application of Pneumococcal Vaccines
1.3.1 For Infants
1.3.2 For Children (2-10)
1.3.3 For Person (10-64)
1.3.4 For The Old (?65)
1.4 Development History of Pneumococcal Vaccines
1.5 Market Status and Trend of Pneumococcal Vaccines 2013-2023
1.5.1 Europe Pneumococcal Vaccines Market Status and Trend 2013-2023
1.5.2 Regional Pneumococcal Vaccines Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Pneumococcal Vaccines in Europe 2013-2017
2.2 Consumption Market of Pneumococcal Vaccines in Europe by Regions
2.2.1 Consumption Volume of Pneumococcal Vaccines in Europe by Regions
2.2.2 Revenue of Pneumococcal Vaccines in Europe by Regions
2.3 Market Analysis of Pneumococcal Vaccines in Europe by Regions
2.3.1 Market Analysis of Pneumococcal Vaccines in Germany 2013-2017
2.3.2 Market Analysis of Pneumococcal Vaccines in United Kingdom 2013-2017
2.3.3 Market Analysis of Pneumococcal Vaccines in France 2013-2017
2.3.4 Market Analysis of Pneumococcal Vaccines in Italy 2013-2017
2.3.5 Market Analysis of Pneumococcal Vaccines in Spain 2013-2017
2.3.6 Market Analysis of Pneumococcal Vaccines in Benelux 2013-2017
2.3.7 Market Analysis of Pneumococcal Vaccines in Russia 2013-2017
2.4 Market Development Forecast of Pneumococcal Vaccines in Europe 2018-2023
2.4.1 Market Development Forecast of Pneumococcal Vaccines in Europe 2018-2023
2.4.2 Market Development Forecast of Pneumococcal Vaccines by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Pneumococcal Vaccines in Europe by Types
3.1.2 Revenue of Pneumococcal Vaccines in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Pneumococcal Vaccines in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Pneumococcal Vaccines in Europe by Downstream Industry
4.2 Demand Volume of Pneumococcal Vaccines by Downstream Industry in Major Countries
4.2.1 Demand Volume of Pneumococcal Vaccines by Downstream Industry in Germany
4.2.2 Demand Volume of Pneumococcal Vaccines by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Pneumococcal Vaccines by Downstream Industry in France
4.2.4 Demand Volume of Pneumococcal Vaccines by Downstream Industry in Italy
4.2.5 Demand Volume of Pneumococcal Vaccines by Downstream Industry in Spain
4.2.6 Demand Volume of Pneumococcal Vaccines by Downstream Industry in Benelux
4.2.7 Demand Volume of Pneumococcal Vaccines by Downstream Industry in Russia
4.3 Market Forecast of Pneumococcal Vaccines in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PNEUMOCOCCAL VACCINES
5.1 Europe Economy Situation and Trend Overview
5.2 Pneumococcal Vaccines Downstream Industry Situation and Trend Overview
CHAPTER 6 PNEUMOCOCCAL VACCINES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Pneumococcal Vaccines in Europe by Major Players
6.2 Revenue of Pneumococcal Vaccines in Europe by Major Players
6.3 Basic Information of Pneumococcal Vaccines by Major Players
6.3.1 Headquarters Location and Established Time of Pneumococcal Vaccines Major Players
6.3.2 Employees and Revenue Level of Pneumococcal Vaccines Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PNEUMOCOCCAL VACCINES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Pfizer
7.1.1 Company profile
7.1.2 Representative Pneumococcal Vaccines Product
7.1.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Pfizer
7.2 Sanofi
7.2.1 Company profile
7.2.2 Representative Pneumococcal Vaccines Product
7.2.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Sanofi
7.3 GSK
7.3.1 Company profile
7.3.2 Representative Pneumococcal Vaccines Product
7.3.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of GSK
7.4 Merck
7.4.1 Company profile
7.4.2 Representative Pneumococcal Vaccines Product
7.4.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Merck
7.5 Eli Lilly
7.5.1 Company profile
7.5.2 Representative Pneumococcal Vaccines Product
7.5.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Eli Lilly
7.6 AstraZeneca
7.6.1 Company profile
7.6.2 Representative Pneumococcal Vaccines Product
7.6.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of AstraZeneca
7.7 Abera
7.7.1 Company profile
7.7.2 Representative Pneumococcal Vaccines Product
7.7.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Abera
7.8 S K Chemicals
7.8.1 Company profile
7.8.2 Representative Pneumococcal Vaccines Product
7.8.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of S K Chemicals
7.9 Beijing Minhai Biotechnology
7.9.1 Company profile
7.9.2 Representative Pneumococcal Vaccines Product
7.9.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Beijing Minhai Biotechnology
7.10 Baxter
7.10.1 Company profile
7.10.2 Representative Pneumococcal Vaccines Product
7.10.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Baxter
7.11 Biken
7.11.1 Company profile
7.11.2 Representative Pneumococcal Vaccines Product
7.11.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Biken
7.12 Celgene Corporation
7.12.1 Company profile
7.12.2 Representative Pneumococcal Vaccines Product
7.12.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Celgene Corporation
7.13 Panacea Biotec
7.13.1 Company profile
7.13.2 Representative Pneumococcal Vaccines Product
7.13.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Panacea Biotec
7.14 Serum Institute of India
7.14.1 Company profile
7.14.2 Representative Pneumococcal Vaccines Product
7.14.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Serum Institute of India
7.15 Genentech
7.15.1 Company profile
7.15.2 Representative Pneumococcal Vaccines Product
7.15.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Genentech
7.16 Genocea Biosciences
7.17 ImmunoBiology
7.18 Lupin
7.19 Nuron Biotech
7.20 Biogen
7.21 Valneva Austria
7.22 Sinovac
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PNEUMOCOCCAL VACCINES
8.1 Industry Chain of Pneumococcal Vaccines
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PNEUMOCOCCAL VACCINES
9.1 Cost Structure Analysis of Pneumococcal Vaccines
9.2 Raw Materials Cost Analysis of Pneumococcal Vaccines
9.3 Labor Cost Analysis of Pneumococcal Vaccines
9.4 Manufacturing Expenses Analysis of Pneumococcal Vaccines
CHAPTER 10 MARKETING STATUS ANALYSIS OF PNEUMOCOCCAL VACCINES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Pneumococcal Vaccines in This Report
1.2 Commercial Types of Pneumococcal Vaccines
1.2.1 PPSV
1.2.2 PCV 7/13
1.2.3 PCV
1.3 Downstream Application of Pneumococcal Vaccines
1.3.1 For Infants
1.3.2 For Children (2-10)
1.3.3 For Person (10-64)
1.3.4 For The Old (?65)
1.4 Development History of Pneumococcal Vaccines
1.5 Market Status and Trend of Pneumococcal Vaccines 2013-2023
1.5.1 Europe Pneumococcal Vaccines Market Status and Trend 2013-2023
1.5.2 Regional Pneumococcal Vaccines Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Pneumococcal Vaccines in Europe 2013-2017
2.2 Consumption Market of Pneumococcal Vaccines in Europe by Regions
2.2.1 Consumption Volume of Pneumococcal Vaccines in Europe by Regions
2.2.2 Revenue of Pneumococcal Vaccines in Europe by Regions
2.3 Market Analysis of Pneumococcal Vaccines in Europe by Regions
2.3.1 Market Analysis of Pneumococcal Vaccines in Germany 2013-2017
2.3.2 Market Analysis of Pneumococcal Vaccines in United Kingdom 2013-2017
2.3.3 Market Analysis of Pneumococcal Vaccines in France 2013-2017
2.3.4 Market Analysis of Pneumococcal Vaccines in Italy 2013-2017
2.3.5 Market Analysis of Pneumococcal Vaccines in Spain 2013-2017
2.3.6 Market Analysis of Pneumococcal Vaccines in Benelux 2013-2017
2.3.7 Market Analysis of Pneumococcal Vaccines in Russia 2013-2017
2.4 Market Development Forecast of Pneumococcal Vaccines in Europe 2018-2023
2.4.1 Market Development Forecast of Pneumococcal Vaccines in Europe 2018-2023
2.4.2 Market Development Forecast of Pneumococcal Vaccines by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Pneumococcal Vaccines in Europe by Types
3.1.2 Revenue of Pneumococcal Vaccines in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Pneumococcal Vaccines in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Pneumococcal Vaccines in Europe by Downstream Industry
4.2 Demand Volume of Pneumococcal Vaccines by Downstream Industry in Major Countries
4.2.1 Demand Volume of Pneumococcal Vaccines by Downstream Industry in Germany
4.2.2 Demand Volume of Pneumococcal Vaccines by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Pneumococcal Vaccines by Downstream Industry in France
4.2.4 Demand Volume of Pneumococcal Vaccines by Downstream Industry in Italy
4.2.5 Demand Volume of Pneumococcal Vaccines by Downstream Industry in Spain
4.2.6 Demand Volume of Pneumococcal Vaccines by Downstream Industry in Benelux
4.2.7 Demand Volume of Pneumococcal Vaccines by Downstream Industry in Russia
4.3 Market Forecast of Pneumococcal Vaccines in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PNEUMOCOCCAL VACCINES
5.1 Europe Economy Situation and Trend Overview
5.2 Pneumococcal Vaccines Downstream Industry Situation and Trend Overview
CHAPTER 6 PNEUMOCOCCAL VACCINES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Pneumococcal Vaccines in Europe by Major Players
6.2 Revenue of Pneumococcal Vaccines in Europe by Major Players
6.3 Basic Information of Pneumococcal Vaccines by Major Players
6.3.1 Headquarters Location and Established Time of Pneumococcal Vaccines Major Players
6.3.2 Employees and Revenue Level of Pneumococcal Vaccines Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PNEUMOCOCCAL VACCINES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Pfizer
7.1.1 Company profile
7.1.2 Representative Pneumococcal Vaccines Product
7.1.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Pfizer
7.2 Sanofi
7.2.1 Company profile
7.2.2 Representative Pneumococcal Vaccines Product
7.2.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Sanofi
7.3 GSK
7.3.1 Company profile
7.3.2 Representative Pneumococcal Vaccines Product
7.3.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of GSK
7.4 Merck
7.4.1 Company profile
7.4.2 Representative Pneumococcal Vaccines Product
7.4.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Merck
7.5 Eli Lilly
7.5.1 Company profile
7.5.2 Representative Pneumococcal Vaccines Product
7.5.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Eli Lilly
7.6 AstraZeneca
7.6.1 Company profile
7.6.2 Representative Pneumococcal Vaccines Product
7.6.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of AstraZeneca
7.7 Abera
7.7.1 Company profile
7.7.2 Representative Pneumococcal Vaccines Product
7.7.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Abera
7.8 S K Chemicals
7.8.1 Company profile
7.8.2 Representative Pneumococcal Vaccines Product
7.8.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of S K Chemicals
7.9 Beijing Minhai Biotechnology
7.9.1 Company profile
7.9.2 Representative Pneumococcal Vaccines Product
7.9.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Beijing Minhai Biotechnology
7.10 Baxter
7.10.1 Company profile
7.10.2 Representative Pneumococcal Vaccines Product
7.10.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Baxter
7.11 Biken
7.11.1 Company profile
7.11.2 Representative Pneumococcal Vaccines Product
7.11.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Biken
7.12 Celgene Corporation
7.12.1 Company profile
7.12.2 Representative Pneumococcal Vaccines Product
7.12.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Celgene Corporation
7.13 Panacea Biotec
7.13.1 Company profile
7.13.2 Representative Pneumococcal Vaccines Product
7.13.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Panacea Biotec
7.14 Serum Institute of India
7.14.1 Company profile
7.14.2 Representative Pneumococcal Vaccines Product
7.14.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Serum Institute of India
7.15 Genentech
7.15.1 Company profile
7.15.2 Representative Pneumococcal Vaccines Product
7.15.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Genentech
7.16 Genocea Biosciences
7.17 ImmunoBiology
7.18 Lupin
7.19 Nuron Biotech
7.20 Biogen
7.21 Valneva Austria
7.22 Sinovac
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PNEUMOCOCCAL VACCINES
8.1 Industry Chain of Pneumococcal Vaccines
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PNEUMOCOCCAL VACCINES
9.1 Cost Structure Analysis of Pneumococcal Vaccines
9.2 Raw Materials Cost Analysis of Pneumococcal Vaccines
9.3 Labor Cost Analysis of Pneumococcal Vaccines
9.4 Manufacturing Expenses Analysis of Pneumococcal Vaccines
CHAPTER 10 MARKETING STATUS ANALYSIS OF PNEUMOCOCCAL VACCINES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
